Securities Registration: Employee Benefit Plan (s-8)
18 Agosto 2020 - 7:23AM
Edgar (US Regulatory)
As filed with the United States Securities
and Exchange Commission on August 17, 2020
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
NEW FRONTIER HEALTH CORPORATION
(Exact Name of Registrant as Specified
in Its Charter)
|
Cayman Islands
|
|
N/A
|
|
(State or Other Jurisdiction of Incorporation or Organization)
|
|
(I.R.S. Employer Identification No.)
|
10 Jiuxianqiao Road,
Hengtong Business Park
B7 Building, 1/F
Chaoyang District, 100015,
Beijing, China
(Address of Registrant’s Principal
Executive Offices)
New Frontier Health Corporation 2019
Omnibus Incentive Plan
(Full title of the plan)
Edward Truitt
Maples Fiduciary Services (Delaware)
Inc.
4001 Kennett Pike, Suite 302
Wilmington, Delaware 19807
(Name, Address, and Telephone Number of
Agent for Service)
Copies to:
Joel L. Rubinstein
Jonathan P. Rochwarger
Elliott M. Smith
White & Case LLP
1221 Avenue of the Americas
New York, New York 10020
Tel: (212) 819-8200
Fax: (212) 354-8113
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth
company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting
company,”
and “emerging growth company”
in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer
|
¨
|
|
Accelerated filer
|
x
|
|
Non-accelerated filer
|
¨
|
|
Smaller reporting company
|
¨
|
|
|
|
|
Emerging growth company
|
x
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨
CALCULATION
OF REGISTRATION FEE
|
Title
of securities
to
be registered(1)
|
|
|
Amount
to
be
Registered(2)
|
|
|
|
Proposed
maximum
offering
price
per
share(3)
|
|
|
|
Proposed
maximum
aggregate
offering
price
|
|
|
|
Amount
of
registration
fee(4)
|
|
|
Ordinary Shares, par value $0.0001
per share
|
|
|
13,850,087
|
(5)
|
|
$
|
7.92
|
|
|
$
|
109,692,689.04
|
|
|
$
|
14,238.11
|
|
|
|
(1)
|
The ordinary shares, par value $0.0001 per share (the “ordinary shares”) of New Frontier
Health Corporation (the “Registrant”) being registered relate to awards to be undertaken in the future, with such terms
and vesting conditions, as applicable, to be determined in accordance with the provisions of the New Frontier Health Corporation
2019 Omnibus Incentive Plan (the “Plan”).
|
|
|
(2)
|
Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”),
this Registration Statement also covers any additional ordinary shares of the Registrant which, as a result of share splits, share
dividends, recapitalizations or any other similar transactions effected without the receipt of consideration, are issued in accordance
with the provisions of the Plan.
|
|
|
(3)
|
Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c)
and Rule 457(h) of the Securities Act based on the average of the high and low prices of ordinary shares on the New York Stock
Exchange on August 12, 2020.
|
|
|
(4)
|
Calculated pursuant to Section 6(b) of the Securities Act as follows: Proposed maximum aggregate offering price multiplied
by .0001298.
|
|
|
(5)
|
Includes 3,998,314 ordinary shares underlying awards that are deemed "Substitute Awards" under Section 4(d) of the Plan.
|
table of
contents
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
|
|
Item 1.
|
Plan Information.*
|
|
|
Item 2.
|
Registrant Information and Employee Plan Annual Information.*
|
|
|
*
|
The documents containing the information specified in Part I will be delivered in accordance with
Rule 428(b)(1) under the Securities Act. Such documents are not required to be, and are not, filed with the Securities and Exchange
Commission (the “Commission”), either as part of this Registration Statement or as prospectuses or prospectus supplements
pursuant to Rule 424 under the Securities Act. These documents, and the documents incorporated by reference in this Registration
Statement pursuant to Item 3 of Part II of this Form S-8, taken together, constitute a prospectus that meets the requirements of
Section 10(a) of the Securities Act.
|
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
|
|
Item 3.
|
Incorporation of Documents by Reference.
|
The Registrant hereby
incorporates by reference in to this Registration Statement the following documents previously filed with the Commission:
|
|
1.
|
The Registrant’s Annual Report on Form 20-F for the fiscal year ended December 31, 2019 filed
with the Commission on March 31, 2020, pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including the description
of the ordinary shares of the Registrant contained in Exhibit 2.5 thereto; and
|
|
|
2.
|
The description of the Registrant’s ordinary shares contained in the Registrant’s Registration
Statement on Form 8-A, as filed with the Commission on June 26, 2018, including any amendment or report filed for the purpose of updating such description (File No. 001-38562).
|
Furthermore,
all reports and other documents subsequently filed by the Registrant with the Commission pursuant to Sections 13(a), 13(c), 14,
or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) prior to the filing of a post-effective
amendment to this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities
then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be a part of this Registration
Statement from the date of filing of such reports and documents; provided, however, that documents or information deemed to have
been furnished and not filed in accordance with the rules of the Commission should not be deemed incorporated by reference in this
Registration Statement.
Any
statement contained in any document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified
or superseded for purposes of this Registration Statement to the extent that a statement contained in this Registration Statement
or in any other subsequently filed document which also is or is deemed to be incorporated by reference in this Registration Statement
modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified
or superseded, to constitute a part of this Registration Statement.
|
|
Item 4.
|
Description of Securities.
|
Not applicable.
|
|
Item 5.
|
Interests of Named Experts and Counsel.
|
Not applicable.
|
|
Item 6.
|
Indemnification of Directors and Officers.
|
Cayman Islands law
does not limit the extent to which a company’s memorandum and articles of association may provide for indemnification of
officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public
policy, such as to provide indemnification against willful default, willful neglect, civil fraud or the consequences of committing
a crime. Our amended and restated memorandum and articles of association provides for indemnification of our officers and directors
to the maximum extent permitted by law, including for any liability incurred in their capacities as such, except through their
own actual fraud, willful default or willful neglect. The Registrant has purchased a policy of directors’ and officers’
liability insurance that insures our officers and directors against the cost of defense, settlement or payment of a judgment in
some circumstances and insures us against our obligations to indemnify our officers and directors.
Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to
the foregoing provisions, the Registrant has been informed that in the opinion of the Commission such indemnification is against
public policy as expressed in the Securities Act and is therefore unenforceable.
The Registrant has
entered into an indemnification agreement with each of our directors and executive officers. The indemnification agreements provide
our directors and executive officers with contractual rights to the indemnification and expense advancement rights, as well as
contractual rights to additional indemnification as provided in the indemnification agreement.
|
|
Item 7.
|
Exemption from Registration Claimed.
|
Not applicable.
|
|
(a)
|
The undersigned Registrant hereby undertakes:
|
(1) To
file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
(i)
to include any prospectus required by Section 10(a)(3) of the
Securities Act;
(ii) to
reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high
end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission
(the “Commission”) pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more
than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table
in the effective registration statement; and
(iii) to
include any material information with respect to the plan of distribution not previously disclosed in the registration statement
or any material change to such information in the registration statement;
provided, however,
that:
Paragraphs
(i) and (ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained
in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange
Act, that are incorporated by reference in the registration statement.
(2) That,
for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof.
(3) To
remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.
(4) If the Registrant is a foreign private issuer, to file a post-effective amendment
to the registration statement to include any financial statements required by Item 8.A of Form 20-F at the start of any
delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section
10(a)(3) of the Securities Act need not be furnished, provided that the Registrant includes in the prospectus, by means of a
post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other information necessary to
ensure that all other information in the prospectus is at least as current as the date of those financial statements.
Notwithstanding the foregoing, with respect to registration statements on Form F-3, a post-effective amendment need not be
filed to include financial statements and information required by Section 10(a)(3) of the Securities Act or Item 8.A of Form
20-F if such financial statements and information are contained in periodic reports filed with or furnished to the Commission
by the Registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by
reference in the Form F-3.
(5) That,
for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant
to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report
pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof.
(c) Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons
of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the
Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In
the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred
or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding)
is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant
will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will
be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements
of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in Beijing, China on August 17, 2020.
|
|
NEW FRONTIER HEALTH CORPORATION
|
|
|
|
|
|
|
/s/ Roberta Lipson
|
|
|
|
Name:
|
|
Roberta Lipson
|
|
|
|
Title:
|
|
Chief Executive Officer
|
|
POWER OF
ATTORNEY
KNOW ALL PERSONS BY
THESE PRESENTS, that each person whose signature appears below constitutes and appoints Roberta Lipson, Antony Leung, Carl Wu and
David Zeng, and each one of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and
resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any and all amendments
to the Registration Statement on Form S-8 of New Frontier Health Corporation and any subsequent registration statements related
thereto pursuant to Instruction E to Form S-8 (and all further amendments including post-effective amendments thereto), and to
file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act
and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could
do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his, her or their substitute
or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements
of the Securities Act of 1933, this registration statement has been signed below by the following persons on behalf of the Registrant,
New Frontier Health Corporation, in the capacities and on the date indicated.
|
Signature
|
|
Capacity
in Which Signed
|
|
Date
|
|
|
|
|
|
/s/ Roberta Lipson
|
|
Chief Executive Officer and Director (Principal Executive Officer)
|
|
August 17, 2020
|
|
Roberta Lipson
|
|
|
|
|
|
|
|
|
|
/s/ Walter Xue
|
|
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
|
August 17, 2020
|
|
Walter Xue
|
|
|
|
|
|
|
|
|
|
/s/ Antony Leung
|
|
Chairman of the Board
|
|
August 17, 2020
|
|
Antony Leung
|
|
|
|
|
|
|
|
|
|
/s/ Carl Wu
|
|
Director
|
|
August 17, 2020
|
|
Carl Wu
|
|
|
|
|
|
|
|
|
|
/s/ Qiyu Chen
|
|
Director
|
|
August 17, 2020
|
|
Qiyu Chen
|
|
|
|
|
|
|
|
|
|
/s/ Shan Fu
|
|
Director
|
|
August 17, 2020
|
|
Shan Fu
|
|
|
|
|
|
|
|
|
|
/s/ David Zeng
|
|
Director
|
|
August 17, 2020
|
|
David Zeng
|
|
|
|
|
|
|
|
/s/ Edward Leong Che-hung
|
|
Director
|
|
August 17, 2020
|
|
Edward Leong Che-hung
|
|
|
|
|
|
|
|
|
|
/s/ Frederick Ma Si-hang
|
|
Director
|
|
August 17, 2020
|
|
Frederick Ma Si-hang
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Lawrence Chia
|
|
Director
|
|
August 17, 2020
|
|
Lawrence Chia
|
|
|
|
|
AUTHORIZED REPRESENTATIVE
Pursuant to the requirements
of Section 6(a) of the Securities Act of 1933, the undersigned has signed this registration statement, solely in its capacity as
the duly authorized representative of New Frontier Health Corporation, in the City of Newark, State of Delaware, on the 17th day
of August, 2020.
|
|
By:
|
/s/ Donald Puglisi
|
|
|
|
Name: Donald Puglisi
|
|
|
|
Title: Authorized Representative
|
|
New Frontier Health (NYSE:NFH)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
New Frontier Health (NYSE:NFH)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
